Pregnancy complications and chemokine expression in smokers
Creators: name: University Of California Office Of The President
Publisher: name: University of California Office of the President
publisherIdentifier: https://ror.org/00dmfq477
publisherIdentifierScheme: ROR
Year: 2024

description: Smoking during pregnancy greatly increases the risk of pregnancy complications. While many negative pregnancy outcomes occur as the result of smoking, the two most common complications are spontaneous abortion (miscarriage) and intra-uterine growth retardation, a condition in which the fetus does not grow rapidly enough during gestation and, as a result, is born very small. These low birth weight babies have multiple health problems because of their small size, and many are transferred to neonatal intensive care units immediately after birth. Perinatal (during the last half of pregnancy) and neonatal (the first 28 days after birth) deaths are increased 33% in children of smoking mothers (Lambers and Clark, 1996). This increase in the death rate is probably directly attributable to the increased incidence of low birth weight babies born to smoking mothers. Population studies suggest that in the United States 20-30% of low birth weights are caused by maternal cigarette use (Kleinman et al., 1987).
 
 
 
 
 
 The biological basis for this increase in spontaneous abortions and intra-uterine growth retardation among smoking mothers is the toxic effect of cigarette smoke on an organ unique to pregnancy - the placenta. The placenta is a transient organ that develops from fetal tissues during pregnancy. It performs tasks that are vital for the maintenance of pregnancy and for the correct growth and development of the fetus. For example, pregnancy begins when placental cells attach the embryo to the mother's uterus. Once pregnancy is established, a child must develop in the uterus for many months before its organ systems can function on their own. During this time the placenta carries out, for the child, the roles played by many important organs including the heart, lungs, digestive system and kidneys. Thus, throughout this critical period, toxic substances that harm the placenta likewise harm the developing child.
 
 
 
 
 
 Previous studies from the Fisher lab have shown that the placenta is vulnerable to the toxic effects of maternal tobacco use. Smoking interferes with the way placental cells attach to the uterus, and subsequently, with the way they function. This application focuses on the effects of cigarette smoking on a particular function of placental cells, their ability to recruit maternal immune cells to the pregnant uterus. In non-smoking pregnancies, the uterus is infiltrated by many maternal immune cells, and evidence suggests that these cells support the proper development and growth of the placenta. It is possible that in smoking mothers this cooperation between the placenta and the maternal immune system is disrupted.
 
 
 
 
 
 In spite of the severe negative consequences of maternal smoking on pregnancy outcome, studies suggest that approximately 20-30% of pregnant women in this country smoke (CDC, 1991; Overpeck and Moss, 1991). We envision that the results of our investigation could be used in cessation programs to help women quit smoking during pregnancy. Data suggest that pregnancy is an ideal time to intervene, since many women reduce or stop cigarette consumption upon learning that they are pregnant (O'Campo et al., 1995). However, the effectiveness of cessation programs in this population is greatly enhanced when pregnancy specific materials are available for use as counseling tools (Dolan-Mullen et al., 1994). It is likely that a subset of mothers who smoke during pregnancy will be more likely to quit if they better understand the added risk their infants incur as a result of their cigarette use. A simple explanation of how smoking harms the conceptus, one possible outcome of our work, could be an important part of these specially designed materials.